ketanserin has been researched along with Cancer of Lung in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Drozdov, I | 1 |
Kidd, M | 1 |
Gustafsson, BI | 1 |
Svejda, B | 1 |
Joseph, R | 1 |
Pfragner, R | 1 |
Modlin, IM | 1 |
Skolnik, G | 1 |
Ivarsson, L | 1 |
Bagge, U | 1 |
2 other studies available for ketanserin and Cancer of Lung
Article | Year |
---|---|
Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines.
Topics: Cell Line, Tumor; Cell Proliferation; Homeostasis; Humans; Intestinal Neoplasms; JNK Mitogen-Activat | 2009 |
The influence of antiserotonin treatment with ketanserin on the pulmonary lodgement of circulating tumour cells in normal and traumatized rats.
Topics: Animals; Femoral Fractures; Fibrosarcoma; Ketanserin; Lung Neoplasms; Neoplasm Transplantation; Neop | 1983 |